Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas
Open accessThe DOI matches its Crossref record; 87 of the 88 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Trousseau described spontaneous, recurrent superficial migratory thrombophlebitis associated with occult cancers, and this was later correlated with disseminated microangiopathy (platelet-rich clots in small blood vessels). Trousseau syndrome often occurs with mucinous adenocarcinomas, which secrete abnormally glycosylated mucins and mucin fragments into the bloodstream. Since carcinoma mucins can have binding sites for selectins, we hypothesized that selectin-mucin interactions might trigger this syndrome. When highly purified, tissue-factor free carcinoma mucin preparations were intravenously injected into mice, platelet-rich microthrombi were rapidly generated. This pathology was markedly diminished in P- or L-selectin–deficient mice. Heparin (an antithrombin-potentiating agent that can also block P- and L-selectin recognition of ligands) ameliorated this platelet aggregation, but had no additional effect in P- or L-selectin–deficient mice. Inhibition of endogenous thrombin by recombinant hirudin also did not block platelet aggregation. Mucins generated platelet aggregation in vitro in hirudinized whole blood, but not in platelet-rich leukocyte-free plasma nor in whole blood from L-selectin–deficient mice. Thus, Trousseau syndrome is likely triggered by interactions of circulating carcinoma mucins with leukocyte L-selectin and platelet P-selectin without requiring accompanying thrombin generation. These data may also explain why heparin ameliorates Trousseau syndrome, while vitamin K antagonists that merely depress thrombin production do not.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Indeed, extended segments of some mucins are even resistant to broad-spectrum proteases like proteinase K (511 -512).”
From Biological roles of glycans (2017) · cites this paper as [511]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevilacqua, M. P., Stengelin, S., Gimbrone, M. A., & Seed, B. (1989) · Science · doi:10.1126/science.2466335 · Cited by 2,005
Selectins and their ligands: Current concepts and controversies
Kansas, G. (1996) · Blood · doi:10.1182/blood.v88.9.3259.bloodjournal8893259 · Cited by 1,415
Varki, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7390 · Cited by 946
Self-citationMeyer, G., Marjanovic, Z., Valcke, J., Lorcerie, B., Gruel, Y., Solal-Celigny, P., Le Maignan, C., Extra, J. M., Cottu, P., & Farge, D. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.15.1729 · Cited by 796
Borsig, L., Wong, R., Feramisco, J., Nadeau, D. R., Varki, N. M., & Varki, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061615598 · Cited by 714 · cited 4×
“Immunodeficient RAG2–/– mice (129S6/SvEvTac-Rag2tm1; Taconic Farms, Germantown, New York, USA) and wild-type (C57bl/6J), P-selectin–deficient (P-sel–/–) (B6;129S-SelptmpHyn), and L-selectin–deficient (L-sel–/–) (B6;129S-SelltmlHyn) mouse strains were obtained from The Jackson Laboratory (Bar Harbor, Maine, USA) and cr…”
InfluentialSelf-citationSack, G. H., Levin, J., & Bell, W. R. (1977) · PubMed · Cited by 669
Molecular Cloning of the CA125 Ovarian Cancer Antigen
Yin, B. W. T., & Lloyd, K. O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103554200 · Cited by 617
P-selectin induces the expression of tissue factor on monocytes.
Celi, A., Pellegrini, G., Lorenzet, R., De Blasi, A., Ready, N., Furie, B. C., & Furie, B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8767 · Cited by 590
SACK, G. H., LEVIN, J., & BELL, W. R. (1977) · Medicine · doi:10.1097/00005792-197701000-00001 · Cited by 584
The Structure and Assembly of Secreted Mucins
Perez-Vilar, J., & Hill, R. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.31751 · Cited by 531
Research works printed but not linked: 4
- Trousseau, A. 1868. Lectures on clinical medicine, delivered at the Hotel-Dieu, Paris. P.V. Bazire, editor and translator. The New Sydenham Society Publications. London, United Kingdom. 55 :281-332.
- Rhodes, J.M. 1999. Usefulness of novel tumour markers. Ann. Oncol. 4 (Suppl. 10):118-121. · doi:10.1023/a:1008369626649
- Beeley, J.G. 1985. Glycoprotein and proteoglycan techniques . Elsevier. New York, New York, USA. 73-78.
- Corriveau, D., and Fritsma, J. 1988. Hemostasis and thrombosis in the clinical laboratory . 1988. J.P. Lippincott Co. Philadelphia, Pennsylvania, USA. 443 pp.
Cited by
Items 301–318 of 318
Popper, H. (2025) · Springer eBooks · doi:10.1007/978-3-031-91697-7_18
Alhenc-Gelas, M., Cabel, L., Berger, F., Delaloge, S., Frenel, J., Levy, C., Firmin, N., Ladoire, S., Desmoulins, I., Heudel, P., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13612529
Alhenc-Gelas, M., Cabel, L., Berger, F., Delaloge, S., Frenel, J., Levy, C., Firmin, N., Ladoire, S., Desmoulins, I., Heudel, P., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13612535
Thrombus formation in cancer patients using autopsy materials: an immunohistochemical analysis
Yamada, Y. (2025) · International Journal of Clinical and Experimental Pathology · doi:10.62347/iubz7937
Rôle de la Protéine C, un anticoagulant naturel, dans l’association thrombose et cancer
Besbes, S. (2015) · theses.fr (ABES) · doi:10.70675/3fc43d9ezf299z4399zb4b8zd637bb496f1e
Lim, C.-G., Lee, J., Suk, G., Kim, J.-M., Shim, H., Choi, H. W., Park, J.-Y., Hong, S. J., & Kim, C. (2026) · Nature Communications · doi:10.1038/s41467-026-71344-9
Involvement of platelets in inflammation and cancer
Mezouar, S. (2015) · theses.fr (ABES) · doi:10.70675/3209f579z7718z497fzbe5dzd52f700a4270
Microparticles in colorectal and pancreatic cancers
Mège, D. (2016) · theses.fr (ABES) · doi:10.70675/53ccc88ez4c57z4521zabb5z8a40f9335ca7
Mechanobiology of cancer-associated thrombosis: from molecular mechanisms to therapeutic innovation
Wang, Z. T., Hu, Y. R., Zhan, Z., Dupuy, A., Yao, Z., Liu, X., & Ju, L. A. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04411-4 · Cited by 1
Ding, G., Xu, J., & Yao, M. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1834397
Emerging Insights of Management of Venous Thromboembolism in Patients With Cancer
Guan, Z., Li, X., & Zhu, X. (2026) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296261454788
Jansen, R., Gammersbach, S., Kölsche, T., Meuth, S. G., Schmidt‐Pogoda, A., Schreiber, S., Ruck, T., Lee, J., & Gliem, M. (2026) · Journal of Neurology · doi:10.1007/s00415-026-13851-9
Cancer-Associated Nonbacterial Thrombotic Endocarditis: Current Evidence and Clinical Challenges
Alkhanafsa, M., & Alqatati, F. (2026) · Yemen Journal of Medicine · doi:10.63475/yjm.v5i2.0436
Stroke secondary to cancer-associated coagulopathy: a systematic review
Jauregui, C., Arteta, E. G., Enguita, J. M., & Aguirre, M. E. E. (2026) · Journal of Neurology · doi:10.1007/s00415-026-14119-y
Jovanović, D., Sretenović, S., Jovanović, D., Ilic, M., & Djurdjevic, P. (2026) · Clinical Case Reports · doi:10.1002/ccr3.73675
Matsukawa, M., Hirayama, R., Sakaguchi, T., Uekihara, K., Miyamoto, T., Kojima, T., & Suzuki, R. (2026) · The Journal of Japanese College of Angiology · doi:10.7133/jca.26-00015
Contribution of cellular microparticles to pre-thrombotic states
Trappenburg, M. C. (2013) · Research Publications (Maastricht University) · doi:10.26481/dis.20131204mt
Metadata
- Authors
- Wahrenbrock, M., Borsig, L., Le, D., Varki, N., & Varki, A.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Varki, Ajit
- Venue
- Journal of Clinical Investigation
- Published
- 2003-09-15
- Volume
- 112
- Issue
- 6
- Pages
- 853-862
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC193671
- OpenAlex
- W4249976229
- Cited by
- 317
- References
- 87
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 14 · 2023: 8 · 2022: 10 · 2021: 26 · 2020: 18 · 2019: 20 · 2018: 14 · 2017: 13 · 2016: 20 · 2015: 21 · 2014: 13 · 2013: 10 · 2012: 14
- FWCI
- 4.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service
- National Cancer Institute (R01 CA 38701, R01CA038701)
- Topics
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- Trousseau syndrome, mucinous adenocarcinoma, P-selectin, L-selectin, platelet aggregation, microvascular thrombosis, heparin, hirudin, vitamin K antagonists, thrombophlebitis
- MeSH terms
- Animals, Antifibrinolytic Agents, Blood Platelets, Adenocarcinoma, Mucinous, Fibrinolytic Agents, Heparin, Humans, Lung, Mice, Inbred C57BL, Mucins, Neoplasm Transplantation, Paraneoplastic Syndromes, Syndrome, Thrombin, Thrombophlebitis, Thrombosis, Transplantation, Heterologous, Tumor Cells, Cultured, Vitamin K, Platelet Activation, Comorbidity, P-Selectin, L-Selectin, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.